SCHEMBL4670596

SCHEMBL4670596

NC(=O)c1[c]ccc2cc(O)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.36
PARP1 P09874 1/20 0.35
FLT3 P36888 3/20 0.35
CLK1 P49759 2/20 0.34
LMNA P02545 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
BRCA1 P38398 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
F12 P00748 1/20 0.33
KCNJ11 Q14654 1/20 0.33
HNF4A P41235 1/20 0.32
AKR1B1 P15121 1/20 0.32
DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3785573 0.83 LCK (0.44) LCKPARP1KDM4EALDH1A1HPGD
SCHEMBL1229740 0.77 KDM4E (0.43) PARP1KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL5749006 0.76 KDM4E (0.54) PARP1KDM4EALDH1A1GAAGLA
Hydrochloric Acid SCHEMBL8169298 0.75 KDM4E (0.42) PARP1KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL5034793 0.74 CYP1A2 (0.38) LMNAKDM4EALDH1A1GAASMN1; SMN2
SCHEMBL28433291 0.71 CYP1A2 (0.40) LMNAKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL10708476 0.71 ESR1 (0.37) LMNAKDM4EALDH1A1GAASMN1; SMN2
SCHEMBL28302283 0.70 ESR1 (0.33) FLT3LMNAKDM4EALDH1A1GAA
SCHEMBL1807859 0.68 KDM4E (0.62) LCKPARP1CLK1KDM4EALDH1A1
SCHEMBL4670538 0.68 POLB (0.34) KDM4EALDH1A1GAAPOLBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397341-B1 6-(ARYL-AMIDO OR ARYL-AMIDOMETHYL)-NAPHTHALEN-2-YLOXY-ACIDIC DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) WYETH CORP (US) 2008-08-06 EP disclosed
EP-1397341-A1 6-(ARYL-AMIDO OR ARYL-AMIDOMETHYL)-NAPHTHALEN-2-YLOXY-ACIDIC DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) Wyeth (US) 2004-03-17 EP disclosed
US-6589970-B2 This invention provides novel compounds, pharmaceutical compositions and methods of treating thrombotic disorders in mammals, the compounds having the formula: WYETH 2003-07-08 US disclosed
US-20030045560-A1 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) WYETH 2003-03-06 US disclosed
WO-2003000649-A1 6-(ARYL-AMIDO OR ARYL-AMIDOMETHYL)-NAPHTHALEN-2-YLOXY-ACIDIC DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) WYETH (US) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045560-A1 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) SERPINC1, F11, SERPINE1 LCK 4537/4885PARP1 412/4885FLT3 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.